IP Library › Granted Patent US 8,618,090
Granted Patent B2
US 8,618,090 · App. 13/055,104 · Granted Dec 31, 2013

Inhibitors of the plasmodial surface anion channel as antimalarials

Inventors: Sanjay A. Desai (Potomac, MD); Ajay D. Pillai (Andhra Pradesh, IN)
Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,618,090
App. No.
13/055,104
Granted
Dec 31, 2013
Kind
B2
Abstract

Disclosed are inhibitors of the plasmodial surface anion channel (PSAC) inhibitors and the use thereof in treating or preventing malaria in an animal such as a human, comprising administering an effective amount of an inhibitor or a combination of inhibitors. An example of such an inhibitor is a compound of formula I, Formula (I) or a pharmaceutically acceptable salt thereof, wherein R 1 to R 7 are as described herein.

Claims (29)

1. A method of providing prophylaxis to an animal against malaria or treating an animal afflicted with malaria comprising administering to the animal:

(i) an effective amount of a compound of formula I:

wherein R 1 is hydrogen or alkyl and R 2 is arylalkyl, optionally substituted on the aryl with one or more substituents selected from the group consisting of halo, hydroxyl, nitro, cyano, amino, alkyl, aminoalkyl, alkylamino, alkylcarbonyl, alkoxycarbonyl, aminocarbonyl, and formyl; or R 2 is a group of formula (II):

wherein n=0 to 6;

or R 1 and R 2 together with the N to which they are attached form a heterocycle of formula III:

wherein X is N or CH; and

Y is aryl, alkylaryl, dialkylaryl, arylalkyl, alkoxyaryl, or heterocyclic, optionally substituted with one or more substituents selected from the group consisting of halo, hydroxyl, nitro, cyano, amino, aminoalkyl, alkylamino, alkylcarbonyl, alkoxycarbonyl, aminocarbonyl, and formyl; and

R 3 -R 10 are hydrogen or alkyl; or a pharmaceutically acceptable salt thereof.

2. The method of claim 1 , wherein R 3 in formula I is hydrogen.

3. The method of claim 1 , wherein R 4 -R 7 in formula I are hydrogen.

4. The method of claim 1 , wherein R 1 in formula I is hydrogen or alkyl and R 2 is a group of formula II, wherein n=1 to 6.

5. The method of claim 4 , wherein n=2 to 4.

6. The method of claim 1 , wherein R I and R 2 together with the N to which they are attached form a heterocycle of formula III.

7. The method of claim 1 , wherein X in formula III is N.

8. The method of claim 7 , wherein in formula III, Y is aryl which is optionally substituted with one or more substituents selected from the group consisting of halo, hydroxyl, nitro, cyano, amino, alkyl, alkoxy, aminoalkyl, alkylamino, alkylcarbonyl, alkoxycarbonyl, aminocarbonyl, and formyl.

9. The method of claim 8 , wherein in formula III, Y is phenyl, which is optionally substituted with one or more substituents selected from the group consisting of halo, hydroxyl, nitro, cyano, amino, alkyl, alkoxy, aminoalkyl, alkylamino, alkylcarbonyl, alkoxycarbonyl, aminocarbonyl, and formyl.

10. The method of claim 9 , wherein Y is phenyl or phenyl substituted with one or more substituents selected from the group consisting of methyl, chloro, fluoro, and methoxy.

11. The method of claim 1 , wherein the compound of formula I is:

12. The method of claim 1 , wherein X in formula III is CH.

13. The method of claim 12 , wherein Y is arylalkyl or heterocyclic, which is optionally substituted with one or more substituents selected from the group consisting of halo, hydroxyl, nitro, cyano, amino, alkyl, aminoalkyl, alkylamino, alkylcarbonyl, alkoxycarbonyl, aminocarbonyl, and formyl.

14. The method of claim 13 , Y is benzyl or piperidinyl, which is optionally substituted with one or more substituents selected from the group consisting of halo, hydroxyl, nitro, cyano, amino, alkyl, aminoalkyl, alkylamino, alkylcarbonyl, alkoxycarbonyl, aminocarbonyl, and formyl.

15. The method of claim 12 , wherein the compound of formula I is:

16. The method of claim 1 , wherein R 1 in formula I is hydrogen and R 2 is arylalkyl, optionally substituted on the aryl with a substituent selected from the group consisting of halo, hydroxyl, nitro, cyano, amino, alkyl, aminoalkyl, alkylamino, alkylcarbonyl, and formyl.

17. The method of claim 16 , wherein R 2 is arylalkyl.

18. The method of claim 17 , wherein R 2 is phenylalkyl.

19. The method of claim 18 , wherein the phenylalkyl is phenylbutyl.

20. The method of claim 19 , wherein the compound of formula I is:

21. The method of claim 5 , wherein the compound of formula II is:

22. The method of claim 1 , wherein said animal is a human.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2011
From: DESAI, SANJAY A.; PILLAI, AJAY D.
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 025855/0065 →
Continuity (2)
Provisional Application 61083000 · Jul 23, 2008
Related Publication 20110144086A1 · Jun 16, 2011